For research use only. Not for therapeutic Use.
SRI 31215 (TFA) (Cat.No:I019201), a triplex inhibitor of matriptase, hepsin and hepatocyte growth factor activator (HGFA) with IC50s of 0.69 μM, 0.65 μM, 0.3 μM, blocks pro-HGF activation and thus mimics the activity of HAI-1/2.
Catalog Number | I019201 |
CAS Number | 1832686-44-8 |
Molecular Formula | C₂₇H₃₄F₃N₅O₃ |
Purity | ≥95% |
Target | c-Met/HGFR |
Reference | [1]. Owusu BY, et al. Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling. Oncotarget. 2016 May 17;7(20):29492-506. |